Return to Main Menu
|
COM dean addresses students, faculty
Editor’s
note: On Jan. 31, College of Medicine Dean Jerry Reves, M.D., presented
his State of the College speech to COM students and faculty. Following
is an edited version of his speech. For the unedited version, visit http://www.musc.edu/catalyst/archive/2006/address.html.
by Jerry
Reves, M.D.
Dean,
College of Medicine
Welcome to the fifth annual address to our faculty, students and staff
regarding the state of the College of Medicine.
I am honored to speak with you about our college, its accomplish-ments,
and our future.
Being the oldest medical school in the South, and at one time before
the Civil War, arguably one of the best in the country, we have yet to
reach our proper place among all American medical schools. In other
words, as good as things are, and they are better than ever, I know
that we are committed to reaching greater heights in our own
professional development and the development of our college.
It's important to focus on five categories: 1) a report card on the
2005 goals; 2) mentioning other accomplishments; 3) highlight a few of
the individual achievements; 4) review three concerns and, 5) discuss
goals for 2006.
Dean's
Report Card
I believe the faculty should hold the dean and other leaders
accountable for achieving goals. I’m happy to report that our most
immediate goal last year was to receive LCME accreditation of the
medical school.
We were site visited in January by the LCME and in the summer received
an eight-year extension of our accreditation for the medical school.
Dr. Jeff Wong created an education strategic plan based on a retreat
with college leaders interested in our undergraduate educational
offerings. That plan is in the process of being implemented.
A university research space plan was developed under the leadership of
the provost and has been adopted, but not yet fully implemented. This
plan rewards scientific and academic productivity and provides
incentives for growth in this area as well as penalties for less
productive use of our research space.
As you know we have created a single Neurosciences Department and this
department is continuing to thrive, recruit well and enhance its
educational, research and clinical status.
Our interdisciplinary research and clinical programs are all doing
well.
Veterans
Administration Medical Center
Finally, we have worked hard with the VA to improve our relationship
with this essential and important partner and there are still
exciting possibilities to share more intimately clinical facilities
with the VA.
As an example of interdisciplinary research and clinical care, The
Hollings Cancer Center continues to thrive in all of its domains. The
increase of National Cancer Institute-sponsored research has nearly
tripled in five years.
I mentioned that we have achieved our goal of developing closer
relationships with the VA, but when I addressed you last year, I had no
idea just how intense this work would become. We created four work
groups, many of you served on these work groups to analyze ways that
the VA and MUSC might share equipment, space and other resources to
provide high quality, efficient and effective care to our veteran
patients. I expect us to determine what we will do with the VA as it
relates to new facilities including phase II of our adult hospital.
Graduate
Medical Education Update
Another achievement this year was to formalize the reporting
relationship of Graduate Medical Education (GME). We clarified the
reporting relationship of the designated institutional officer up
through the educational chain of command—COM to the provost and
president and to the Board of Trustees—making it easier to function and
assist the chairs of our clinical departments as they work in educating
our residents and fellows.
We have seen significant increases in the number of under-represented
minorities in our faculty. Likewise in our student body, we have
sustained our increase in the recruitment of under-represented
minorities to the college and we are holding steady.
The Office of Research Development has reported a remarkable increase
in funding since 1997, mostly in this college. The college has nearly
tripled our NIH support in the last five years.
In terms of our national and regional standing in NIH support, we are
ninth of 43 schools in the South. We have some outstanding departments,
with seven ranked in the top 20 nationally, and all of these are in the
top five in the South.
Individual
Achievements
I am aware that it is individuals who do all the work and I thank you
all. I would like to recognize some of our distinguished faculty who
are doing wonderful things in many different areas. They include: Dr.
Jim Norris, president of the International Society of Cancer Gene
Therapy; Dr. Yusuf Hannun, award recipient, Governor’s Award for
Excellence in Scientific Research; Dr. Pearson Lang, president,
American College of Mohs Micrographic Surgery and Cutaneous Oncology;
Dr. Peter Cotton, MUSC Digestive Disease Center for 12 years; Dr.
Lyndon Key and Dr. Bruce Hollis, recently elected, American Pediatrics
Society; Myra Haney, Lowcountry Martin Luther King Jr. Leadership Award
for Education; Dr. Carolyn Reed, president-elect, American Board of
Thoracic Surgery; Dr. David Soper, president, National OB/GYN Society
of Infectious Disease; Dr. Joe Schoepf, considered seventh best world
cardiac imager, Medical Imaging magazine; Dr. John Oldham, fourth
edition text, Diagnostic and Statistical Manual of Mental Disorders;
Dr. Darlene Shaw, recipient MUSC/HSF 2005 Teaching Excellence Award,
Educator-Mentor.
Financial
Issues
There are three major financial concerns I would like to address. I’ve
already mentioned that the NIH is fundamentally flat and we cannot
depend on as much revenue coming from that sector of our activities in
the near term. The clinical enterprise is still healthy, but there are
uncertainties. The institutional infrastructure costs are rising faster
than revenues to defray them. We are in fact running in the red
particularly in utilities.
To deal with the infrastructure problems, a university funds flow
committee is studying the problem.
This brings us to the reality that only $1 comes into the university
and only $1 can be spent. We divide the $1 that comes into the
university with the College of Medicine, other colleges, departments
and UMA. This is the source of funding.
So our strategy is to concentrate on the individual professional
excellence of our faculty to target certain interdisciplinary research
initiatives that are in line with the NIH’s roadmap.
The infrastructure problem (based on increased utility costs and reduce
state support) is running a deficit because these expenses are paid
centrally. About half of the university's indirect $1 stay central. It
is obvious that the budget will never be balanced unless other sources
support the infrastructure. Thus, we are going to have to take a look
at this distribution as part of the infrastructure costs.
Interdisciplinary
Research
Focusing on interdisciplinary research, the college focused on
the NIH roadmap, particularly the interdisciplinary research,
which is the only area in the NIH budget projected to receive
meaningful funding increases in the future.
An NIH initiative was designed to help lower artificial organizational
barriers and advance science. Additionally, there will be a series of
awards to make it easier for scientists to conduct interdisciplinary
research, funding for training of scientists in interdisciplinary
areas, creation of specialized centers to help scientists forge new and
advanced disciplines from existing ones and others to encourage
interdisciplinary planning through the creation of the NIH's Clinical
and Translational Science Awards (CSTA).
The CTSA assist institutions to transform themselves into better
translational research enterprises.
The NIH has pointed out weaknesses in the clinical scientist's
infrastructure both nationally and at MUSC.
Although MUSC has general clinical research centers, training
partnerships and programs in various settings, plus a K-30
curriculum, they are not well integrated into the institutional effort
for translational research.
In preparing us to take this next step, our strengths have been
analyzed—rapid research growth, the endowed chairs program,
center funding, and community ties.
We also have many weaknesses. Examples of this include
insufficient time dedicated to research, low expectations that research
be done in some clinical departments, few incentives for collaboration
across colleges, no incentives and limited protected time for research
mentoring.
Recognizing our strengths and weaknesses, we plan to apply for the CTSA
grant. The RFA issued in October and the first award applications are
due in March. There will be more awards later and we will be applying
for our award in 2007. We will be applying for one of the 50 planning
grants in March and believe we ultimately will be one of the 60 planned
CTSA’s.
Statewide
Initiatives
In addition to our focus on interdisciplinary research initiatives, the
college has many statewide clinical outreach initiatives. Many of these
initiatives have clinical research as part of its work.
In striving to reach our full potential as regional and national
leaders, our potential to work with partners around the state continues
to grow through the Health Sciences South Carolina (HSSC) consortium
that Dr. Ray Greenberg put together. As the major academic medical
center in South Carolina, we can partner and bring our translational
work with other academic physicians and clinicians that are
spread around the state in the Greenville/Spartanburg area and at USC
in Columbia. We have traditionally, and must continue in the future, to
play the lead role in these important statewide initiatives sponsored
by the HSSC.
Our big idea, and one that I believe is absolutely achievable, is that
MUSC and its HSSC partners can be the national, and therefore a global
leader in clinical effectiveness and patient safety. This is an
achievable goal and one that will involve many of our faculty.
Service
Line Management
I mentioned earlier that the one goal we did not achieve this year was
the establishment of service line management of our major clinical
practices. This year we have engaged The Bard Group that specializes in
transforming clinical practices into comprehensive service lines.
The reason to develop service lines or the value proposition for the
establish-ment of these lines is they have the broad impact on an
organization and are a source of pride. They are a method to have a
competitive clinical strategy to improve business performance to
recruit and staff the organization, to develop and cultivate leadership
to make the most of facilities and technologies, and of course a method
for branding.
Comprehensive
Care Programs
At MUSC we strive to create comprehensive, innovative, integrative
programs which invent the future of care and are the superior providers
of that care in our market and our state. We believe we can and are
already doing this in cancer, children’s, digestive, neurosciences and
heart and vascular. These programs are found only in large academic
medical centers. They provide an external reach to the program that is
broad and wide, they insure that we have substantial staff and
resources that foster collaboration within cross-clinical disciplines,
the personnel understand and support centralized planning and
accountability to a leader of the service line and research is an
essential part of inventing the future of patient care.
UMA
The last clinical initiative is for UMA to consider a multi-specialty
clinic in the North Area. This planning will be done in two
phases, the first is to refine a plan and utilize projections about the
feasibility, explore the financial impact and create a business plan
that shows whether or not such a project is viable.
There are a number of possible sites that such a project, if it is
deemed viable, would go, and all are above Ashley Phosphate Road and in
and around the Summerville or Trident Hospital areas.
The possible specialty mix at these sites would be internal medicine
and several of the sub-specialties of ear nose and throat, dermatology
and radiology. We expect this year to conclude phase one of our
planning of this possible clinical initiative.
Moving
Forward in 2006
As I have already mentioned, the goals for next year are to implement a
plan to assist the university in solving its financial issues, to
assist scientists with a formation of a CTSA proposal, recruit a new
director of the DDC.
We will be working hard to plan for the opening of the new hospital and
the best use of backfill space in the old hospital. We will
assist with imple-mentation of the College of Medicine’s
strategic plans in education and research. We will push for an
implementation of the VA/MUSC joint facilities plan, determine which
model to use in the VA/MUSC joint facilities plan.
We will continue to explore ways to find new revenue to support our
critical missions and to stay focused on our major issues that affect
all of you our faculty, students, and staff.
Friday, Feb. 3, 2006
Catalyst Online is published weekly,
updated
as needed and improved from time to time by the MUSC Office of Public
Relations
for the faculty, employees and students of the Medical University of
South
Carolina. Catalyst Online editor, Kim Draughn, can be reached at
792-4107
or by email, catalyst@musc.edu. Editorial copy can be submitted to
Catalyst
Online and to The Catalyst in print by fax, 792-6723, or by email to
catalyst@musc.edu. To place an ad in The Catalyst hardcopy, call Island
papers at 849-1778, ext. 201.
|